Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Total 13F shares
-
49,994,676
-
Share change
-
-960,799
-
Total reported value
-
$547,934,449
-
Put/Call ratio
-
97%
-
Price per share
-
$10.96
-
Number of holders
-
182
-
Value change
-
+$7,051,204
-
Number of buys
-
87
-
Number of sells
-
70
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q1 2023
As of 31 Mar 2023,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
182 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,994,676 shares.
The largest 10 holders included
BlackRock Inc., ARMISTICE CAPITAL, LLC, NEA Management Company, LLC, STATE STREET CORP, CITADEL ADVISORS LLC, Point72 Asset Management, L.P., MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, and VANGUARD GROUP INC.
This page lists
182
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.